CDEK
← All organizations

Fujisawa

For profitContributed to NME

Also known as: Fujisawa GmbH | FUJISAWA HLTHCARE | Fujisawa Pharmaceutical Co

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Nov 2, 1999

First marketed drug

Dec 1, 1991

First NDA

Apr 8, 1994

Last known activity

Feb 1, 2002

Acquired by Astellas → Leo Pharma on Jan 1, 2005

Timeline

1890s

  1. Jan 1, 1894

    Fujisawa— Founded

1990s

  1. Jan 1, 1990

    Lyphomed, Inc.— Acquired

  2. Apr 8, 1994

    tacrolimus— NDA Organization

2000s

  1. Jan 1, 2005

    Astellas— Acquired By

  2. Mar 16, 2005

    micafungin— NDA Secondary Org

2010s

  1. Nov 17, 2015

    Leo Pharma— Now

Drugs by trial phase (4 distinct, 6 trials)

Phase 3 (3 own, 1 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (4)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (4)

Details

Founded
Osaka, JP Jan 1, 1894
First NDA
Apr 8, 1994
Last known activity
Feb 1, 2002

Designations held

  • Priority review